Reuters logo
BRIEF-CDER's Director Woodcock issues statement on investigational use of Keytruda
2017年8月31日 / 下午3点54分 / 3 个月前

BRIEF-CDER's Director Woodcock issues statement on investigational use of Keytruda

Aug 31 (Reuters) - Center for Drug Evaluation and Research:

* Center for Drug Evaluation and Research director Janet Woodcock issues statement regarding safety concerns related to investigational use of Keytruda in multiple myeloma Source text (bit.ly/2xPAHWS) Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below